Welcome to OM Pharma English - Espaņol
Doxium® : Chronic venous insufficiency - Diabetic retinopathy
  Philosophy
  History
  Worldwide activity
  R & D
  Manufacturing
  Products
    Marketing Authorizations
    International Availability
  Main Products
    - Broncho-Vaxom
    - Dicynone
    - Doxium
    - Uro-Vaxom
    Other Products
    - Doxiproct
    - Doxiproct Plus
    - Sinomarin
  Health and Diseases
  News
  Contacts
  Careers and jobs
  Forum


Products
homepage > products > doxium
   
  Doxium
 

Doxium ®500 contains calcium dobesilate as active principle. It acts by normalizing the resistance and permeability of the vascular wall of capillaries and improves venous blood flow.

Doxium ®500 improves blood flow disorders in retinal vessels in case of diabetic retinopathy, as well as in skin diseases linked to chronic venous diseases and haemorrhoids.


 
Information for
healthcare professionals
 
Properties/Effects
 
Composition
 
Pharmacokinetics
 
Indications
 
Dosage and administration
 
Limitations for use
 
Adverse effects
 
Interactions
 
Overdosage
 
Particular remarks
 
Presentation
 
Mechanism of action
Download
 
List of publications PDF file


Doxium
Contact us Back home